Skip to main content

Table 1 Baseline characteristics of the cohort

From: The circadian rest-activity pattern predicts cognitive decline among mild-moderate Alzheimer’s disease patients

 

Global

n=100

n (%) or median [p25;p75]

Sociodemographic data

 Sex

  Female

63 (63.0%)

  Male

37 (37.0%)

 Age, years

76.0 [73.0;80.0]

 BMI, kg·m−2

27.6 [25.1;30.6]

 Education, years

7.00 [7.00;7.00]

Comorbidities

 Hypertension

59 (59.0%)

 Diabetes mellitus

20 (20.0%)

 Cardiopathy

21 (21.0%)

 Depression

28 (28.3%)

 Periodic limb movements

44 (49.4%)

Cognition

 MMSE

23.5 [22.0;25.0]

CSF biomarkers

 Aβ42, pg/ml

533 [402;669]

 T-tau, pg/ml

464 [330;598]

 P-tau, pg/ml

72.3 [53;93]

Genetic risk

 ApoEε4−

41 (41.8%)

  1. ApoEε4− apolipoprotein E carrier, Aβ42 amyloid-beta protein, BMI body mass index, CSF cerebrospinal fluid, MMSE Mini-Mental State Examination, n number, p percentile, P-tau phosphorylated-tau, T-tau total-tau. Missings: Depression, 1; Periodic limb movements, 11; CSF biomarkers, 10; ApoEε4−, 2